$AIMD
Ainos, Inc.

2020 Q1 Form 10-Q Financial Statement

#000101476320000004 Filed on May 15, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1 2018 Q4
Revenue $15.20K $4.076K $10.00K
YoY Change 272.91% -92.8%
Cost Of Revenue $10.81K $2.718K $0.00
YoY Change 297.57% -93.73%
Gross Profit $4.394K $1.358K $0.00
YoY Change 223.56% -89.75%
Gross Profit Margin 28.91% 33.32% 0.0%
Selling, General & Admin $380.3K $389.5K $450.0K
YoY Change -2.36% 95.41% 150.0%
% of Gross Profit 8654.26% 28680.12%
Research & Development $0.00 $2.386K $30.00K
YoY Change -100.0%
% of Gross Profit 0.0% 175.7%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $380.3K $391.9K $490.0K
YoY Change -2.96% 96.61% 172.22%
Operating Profit -$375.9K -$390.5K -$490.0K
YoY Change -3.75% 109.88% 172.22%
Interest Expense -$1.005K $885.00 $0.00
YoY Change -213.56% -35.87% -100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$380.0K -$390.0K -$490.0K
YoY Change -2.56% 105.26% 133.33%
Income Tax
% Of Pretax Income
Net Earnings -$376.9K -$391.4K -$500.0K
YoY Change -3.71% 108.81% 138.1%
Net Earnings / Revenue -2479.47% -9602.28% -5000.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.14 -$0.15 -$0.20
COMMON SHARES
Basic Shares Outstanding 40.52M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 Q1 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $290.0K $1.050M $1.280M
YoY Change -72.38% -38.6% -35.35%
Cash & Equivalents $289.6K $1.046M $1.277M
Short-Term Investments
Other Short-Term Assets $30.00K $20.00K $30.00K
YoY Change 50.0% 100.0% -62.5%
Inventory $4.071K $8.962K
Prepaid Expenses
Receivables $12.58K
Other Receivables $0.00
Total Short-Term Assets $331.9K $1.071M $1.303M
YoY Change -69.02% -37.69% -37.48%
LONG-TERM ASSETS
Property, Plant & Equipment $4.486K $11.02K $14.01K
YoY Change -59.28% -51.46% -48.11%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $147.6K $154.6K $160.5K
YoY Change -4.49% -23.08% -23.36%
TOTAL ASSETS
Total Short-Term Assets $331.9K $1.071M $1.303M
Total Long-Term Assets $147.6K $154.6K $160.5K
Total Assets $479.5K $1.226M $1.464M
YoY Change -60.89% -36.17% -36.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $300.0K $140.0K $120.0K
YoY Change 114.29% 0.0% -25.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $510.0K $480.0K $510.0K
YoY Change 6.25% -30.43% -42.7%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $912.9K $673.8K $733.6K
YoY Change 35.49% -40.91% -59.76%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $912.9K $673.8K $733.6K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $912.9K $673.8K $733.6K
YoY Change 35.49% -40.91% -59.76%
SHAREHOLDERS EQUITY
Retained Earnings -$5.147M -$3.580M -$3.188M
YoY Change 43.77% 66.3% 69.23%
Common Stock $405.2K $395.7K $391.2K
YoY Change 2.4% 17.33% 68.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$433.4K $552.1K $730.1K
YoY Change
Total Liabilities & Shareholders Equity $479.5K $1.226M $1.464M
YoY Change -60.89% -36.17% -36.19%

Cashflow Statement

Concept 2020 Q1 2019 Q1 2018 Q4
OPERATING ACTIVITIES
Net Income -$376.9K -$391.4K -$500.0K
YoY Change -3.71% 108.81% 138.1%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$119.5K -$216.2K -$310.0K
YoY Change -44.74% 182.53% -11.43%
INVESTING ACTIVITIES
Capital Expenditures $1.638K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.638K -$70.00K
YoY Change -2.9% 600.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -12.50K 450.0K
YoY Change -93.59% -79.55%
NET CHANGE
Cash From Operating Activities -119.5K -216.2K -310.0K
Cash From Investing Activities -1.638K -70.00K
Cash From Financing Activities -12.50K 450.0K
Net Change In Cash -119.5K -230.3K 70.00K
YoY Change -48.13% -15.69% -96.2%
FREE CASH FLOW
Cash From Operating Activities -$119.5K -$216.2K -$310.0K
Capital Expenditures $1.638K $0.00
Free Cash Flow -$119.5K -$217.8K -$310.0K
YoY Change -45.15% 184.67% -13.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 amar Common Stock Shares Outstanding And Reserved
CommonStockSharesOutstandingAndReserved
49969579
CY2020Q1 amar Notes Payable Convertible Related Parties Classified Current
NotesPayableConvertibleRelatedPartiesClassifiedCurrent
512464
CY2019Q4 amar Notes Payable Convertible Related Parties Classified Current
NotesPayableConvertibleRelatedPartiesClassifiedCurrent
444581
CY2020Q1 amar Repayments Of Convertible Notes Payable Related Party Debt
RepaymentsOfConvertibleNotesPayableRelatedPartyDebt
CY2019Q1 amar Repayments Of Convertible Notes Payable Related Party Debt
RepaymentsOfConvertibleNotesPayableRelatedPartyDebt
37500
CY2020Q1 amar Stock Issued During Period Value Debt
StockIssuedDuringPeriodValueDebt
CY2020Q1 amar Stock Issued For Accrued Liabilities
StockIssuedForAccruedLiabilities
CY2019Q1 amar Stock Issued For Accrued Liabilities
StockIssuedForAccruedLiabilities
82750
CY2020Q1 us-gaap Gross Profit
GrossProfit
4394
CY2020Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
300393
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
208727
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12578
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4307970
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
405164
CY2020Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:36pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">3.</div></div></div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><div style="display: inline; font-weight: bold;">Basis of presentation.</div> The accompanying consolidated financial statements, which should be read in conjunction with the audited financial statements and footnotes included in the Company's Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019, </div>as filed with the Securities and Exchange Commission on <div style="display: inline; font-style: italic; font: inherit;"> March 30, 2020, </div>have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information. Accordingly, they do <div style="display: inline; font-style: italic; font: inherit;">not</div> include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the <div style="display: inline; font-style: italic; font: inherit;">three</div> months ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020 </div>are <div style="display: inline; font-style: italic; font: inherit;">not</div> necessarily indicative of the results that <div style="display: inline; font-style: italic; font: inherit;"> may </div>be expected for the full year ending <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020.</div></div> </td> </tr> </table></div>
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
289557
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
409039
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4207786
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1276654
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1046314
CY2020Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-119482
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-230340
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40516351
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
90688
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
96149
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
9496
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
9496
CY2020Q1 us-gaap Assets
Assets
479480
CY2019Q4 us-gaap Assets
Assets
596626
CY2020Q1 us-gaap Assets Current
AssetsCurrent
331864
CY2019Q4 us-gaap Assets Current
AssetsCurrent
445294
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40516351
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40516351
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40516351
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
405164
CY2020Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
521115
CY2019Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
452040
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
10806
CY2019Q1 us-gaap Cost Of Revenue
CostOfRevenue
2718
CY2020Q1 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
100000
CY2019Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
100000
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2020Q1 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
143130
CY2019Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
146263
CY2019Q1 us-gaap Gross Profit
GrossProfit
1358
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2019Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2020Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1005
CY2019Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-885
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
69
CY2020Q1 us-gaap Inventory Net
InventoryNet
4071
CY2019Q4 us-gaap Inventory Net
InventoryNet
4131
CY2020Q1 us-gaap Liabilities
Liabilities
912857
CY2019Q4 us-gaap Liabilities
Liabilities
753308
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
479480
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
596626
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
912857
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
753308
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12500
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1638
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-119482
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-216202
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-376879
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-391389
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
CY2019Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
CY2020Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
380268
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
391862
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-375874
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-390504
CY2020Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
CY2019Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1638
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
25658
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32124
CY2020Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
CY2019Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
25000
CY2019Q1 us-gaap Revenues
Revenues
4076
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
380268
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
389476
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
73750
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
34000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-156682
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-433377
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
730079
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
552085
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-433377
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-156682
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-376879
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-391389
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4486
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5069
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2386
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5146511
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4769632
CY2020Q1 us-gaap Revenues
Revenues
15200
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40516351
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39262668

Files In Submission

Name View Source Status
R10.htm Edgar Link pending
0001014763-20-000004-index-headers.html Edgar Link pending
0001014763-20-000004-index.html Edgar Link pending
0001014763-20-000004.txt Edgar Link pending
0001014763-20-000004-xbrl.zip Edgar Link pending
amar-20200331.xml Edgar Link completed
amar-20200331.xsd Edgar Link pending
amar-20200331_cal.xml Edgar Link unprocessable
amar-20200331_def.xml Edgar Link unprocessable
amar-20200331_lab.xml Edgar Link unprocessable
amar-20200331_pre.xml Edgar Link unprocessable
exhibit31-1_03312020.htm Edgar Link pending
exhibit32-1_03312020.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-q_03312020.htm Edgar Link pending
R1.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending